Article Details
Retrieved on: 2025-03-03 15:50:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies like omalizumab (Xolair) target specific immune responses. These therapies block IgE, a key antibody responsible for ...
Article found on: media.market.us
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here